Schedule 13D ownership disclosure

Madrigal Pharmaceuticals Inc

Security class unavailable · CUSIP: 558868105

Event date: 2016-07-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-16-014324
Form type
SC 13D/A
Filer
CAXTON CORP
CIK
CIK 1388551
Filed
Jul 26, 2016
Reporting period
Jul 22, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub